摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,5-Cyclohexadiene-1-carboxaldehyde | 84099-61-6

中文名称
——
中文别名
——
英文名称
1,5-Cyclohexadiene-1-carboxaldehyde
英文别名
1,3-cyclohexadiene-2-carboxaldehyde;3,4-Dihydrobenzaldehyde;cyclohexa-1,5-diene-1-carbaldehyde
1,5-Cyclohexadiene-1-carboxaldehyde化学式
CAS
84099-61-6
化学式
C7H8O
mdl
——
分子量
108.14
InChiKey
OZNGIVMRUKYHSN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1,5-Cyclohexadiene-1-carboxaldehyde甲酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 17.0h, 以99%的产率得到2-(hydroxymethyl)-1,3-cyclohexadiene
    参考文献:
    名称:
    通过高温煅烧 Cu-Al 层状双氢氧化物产生高度还原的 CuO 物质:糠醛与甲酸选择性氢化成糠醇
    摘要:
    通过在空气中在 1073 K 下煅烧 Cu-Al 层状双氢氧化物 (CuAl LDH),可以产生高度还原的 CuO 物质。热处理后,原来的层状双氢氧化物结构完全转变为CuO和CuAl 2 O 4相。合成的煅烧CuAl LDH(calc-CuAl LDH)促进了以甲酸(FA)为氢供体的糠醛(FALD)催化氢化成糠醇(FOL)。在上述催化反应的初始阶段,钙-CuAl LDH 基质中的 CuO 物种通过在液相中形成 Cu(HCOO) 2 -1,4-二恶烷络合物而转化为活性 Cu 0物种。用过的催化剂也可重复使用而不会损失其高催化性能。
    DOI:
    10.1246/bcsj.20210379
  • 作为产物:
    描述:
    2-bromocyclohexa-1,3-diene 以72%的产率得到
    参考文献:
    名称:
    COHEN, T.;BHUPATHY, M.;MATZ, J. R., J. AMER. CHEM. SOC., 1983, 105, N 3, 520-525
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • USE OF COMPOSITIONS OBTAINED BY CALCINING PARTICULAR METAL-ACCUMULATING PLANTS FOR IMPLEMENTING CATALYTICAL REACTIONS
    申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    公开号:US20150376224A1
    公开(公告)日:2015-12-31
    The use of metal-accumulating plants for implementing chemical reactions especially catalytical reactions.
    属积累植物用于实现化学反应,特别是催化反应的使用。
  • Synthetic pentacyclic triterpenoids and derivatives of betulinic acid and betulin
    申请人:Xu Ze-Qi
    公开号:US20070232577A1
    公开(公告)日:2007-10-04
    The present invention comprises small molecule inhibitors of cell proliferative conditions, in particular cancer and conditions associated with cancer. For example, associated malignancies include ovarian cancer, cervical cancer, breast cancer, colorectal cancer, and glioblastomas, among others. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting these diseases. Thus, the present invention also comprising pharmaceutical formulations comprising the compounds and methods of using the compounds and formulations to inhibit cancer and treat, prevent, or inhibit the foregoing diseases.
    本发明包括细胞增殖状况的小分子抑制剂,特别是癌症及与癌症相关的状况。例如,相关的恶性肿瘤包括卵巢癌、宫颈癌、乳腺癌、结直肠癌和胶质母细胞瘤等。因此,本发明的化合物对于治疗、预防和/或抑制这些疾病是有用的。因此,本发明还包括包含这些化合物的药物配方以及使用这些化合物和配方来抑制癌症并治疗、预防或抑制上述疾病的方法。
  • PHOTO ACTIVE AGENTS
    申请人:Hewlett-Packard Development Company, L.P.
    公开号:US20190276482A1
    公开(公告)日:2019-09-12
    The present disclosure is drawn to a photo active agent which includes a bisacylphosphinic compound in the form of an acid or salt having Structure I: where A and A′ are independently aryl or from C2 to C8 lower alkyl; M is H, a monovalent cation, a divalent cation, or mixture thereof; n is 1 or 2; and q is 1 or 2. The photo active agent can be present in a composition that includes from 0.001 wt % to 5 wt % of a dialcohol phosphinic acid precursor or dialcohol phosphinic salt of the bisacylphosphinic compound of Structure I.
    本公开涉及一种光活性剂,其包括一种以酸或盐的形式存在的双酰基膦化合物,具有结构I:其中A和A′分别是芳基或C2至C8低碳链烷基;M是H、一价阳离子、二价阳离子或它们的混合物;n为1或2;q为1或2。该光活性剂可以存在于包含结构I双酰基膦化合物的二元醇膦酸前体或二元醇膦盐,其含量在0.001重量%至5重量%之间的组合物中。
  • Imidazopyrazine tyrosine kinase inhibitors
    申请人:Beck Anne Patricia
    公开号:US20060084654A1
    公开(公告)日:2006-04-20
    Compounds of the formula and pharmaceutically acceptable salts thereof, wherein Q 1 and R 1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of various diseases and conditions that respond to treatment by inhibition of tyrosine kinases.
    该式化合物及其药用盐,其中Q1和R1在此处被定义,抑制IGF-1R酶,并可用于治疗和/或预防对酪氨酸激酶抑制治疗有反应的各种疾病和症状。
  • TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP1942109A1
    公开(公告)日:2008-07-09
    A compound represented by the general formula (1) [X1 and X2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, R1 represents a phenyl group, R2 represents an alkyl group, an alkenyl group, or an alkoxy group, R3 represents hydrogen atom, a halogen atom, hydroxyl group, or an alkoxy group, R4 represents hydrogen atom, or an alkyl group, Z1 and Z2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, Z3 represents cyano group, an alkyl group, an alkenyl group and the like, Z4 represents an alkyl group, an alkenyl group, an alkynyl group and the like, and ---- represents a single bond or a double bond], which shows high antitumor effect against cancer cells including drug resistant cells.
    一个由通式(1)表示的化合物,其中[X1和X2代表氢原子,卤素原子,羟基等,R1代表苯基,R2代表烷基,烯基或烷氧基,R3代表氢原子,卤素原子,羟基或烷氧基,R4代表氢原子或烷基,Z1和Z2代表氢原子,卤素原子,羟基等,Z3代表基,烷基,烯基等,Z4代表烷基,烯基,炔基等,----代表单键或双键],对包括药物耐药细胞在内的癌细胞表现出高抗肿瘤效果。
查看更多